Clinical Trial Update: Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women [Phase 4]

View source ↗

Summary

This Phase 4 trial update investigates the effects of rosiglitazone on bone health in postmenopausal women with type 2 diabetes; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Postmenopausal Osteoporosis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Baskent University | Conditions: Type 2 Diabetes Mellitus, Obesity | Phase 4 | Status: COMPLETED